These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27723532)

  • 1. Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction.
    Lustosa BB; Polegato B; Minicucci M; Rafacho B; Santos PP; Fernandes AA; Okoshi K; Batista D; Modesto P; Gonçalves A; Pereira EJ; Pires V; Paiva S; Zornoff L; Azevedo PS
    Int J Cardiol; 2016 Dec; 225():147-153. PubMed ID: 27723532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats.
    Murino Rafacho BP; Portugal Dos Santos P; Gonçalves AF; Fernandes AAH; Okoshi K; Chiuso-Minicucci F; Azevedo PS; Mamede Zornoff LA; Minicucci MF; Wang XD; Rupp de Paiva SA
    PLoS One; 2017; 12(5):e0177521. PubMed ID: 28494028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green Tea (
    Modesto PN; Polegato BF; Dos Santos PP; Grassi LDV; Molina LCC; Bazan SGZ; Pereira EJ; Fernandes AAH; Fabro AT; Androcioli VN; Roscani MG; de Paiva SAR; Zornoff LAM; Minicucci MF; Azevedo PS
    Oxid Med Cell Longev; 2021; 2021():8898919. PubMed ID: 34035878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization.
    Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spondias mombin L. attenuates ventricular remodelling after myocardial infarction associated with oxidative stress and inflammatory modulation.
    Pereira BLB; Rodrigue A; Arruda FCO; Bachiega TF; Lourenço MAM; Correa CR; Azevedo PS; Polegato BF; Okoshi K; Fernandes AAH; de Paiva SAR; Zornoff LAM; Power KA; Minicucci MF
    J Cell Mol Med; 2020 Jul; 24(14):7862-7872. PubMed ID: 32468694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Re Preserves Cardiac Function and Ameliorates Left Ventricular Remodeling in a Rat Model of Myocardial Infarction.
    Yu Y; Sun J; Liu J; Wang P; Wang C
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):91-97. PubMed ID: 31599782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
    Yurista SR; Silljé HHW; Oberdorf-Maass SU; Schouten EM; Pavez Giani MG; Hillebrands JL; van Goor H; van Veldhuisen DJ; de Boer RA; Westenbrink BD
    Eur J Heart Fail; 2019 Jul; 21(7):862-873. PubMed ID: 31033127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat.
    Mouquet F; Rousseau D; Domergue-Dupont V; Grynberg A; Liao R
    Fundam Clin Pharmacol; 2010 Aug; 24(4):469-76. PubMed ID: 20030737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits.
    Qin F; Liang MC; Liang CS
    Biochim Biophys Acta; 2005 Jun; 1740(3):499-513. PubMed ID: 15949720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.
    Rathinavel A; Sankar J; Mohammed Sadullah SS; Niranjali Devaraj S
    Fundam Clin Pharmacol; 2018 Feb; 32(1):51-59. PubMed ID: 29059499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
    Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.
    Buss SJ; Muenz S; Riffel JH; Malekar P; Hagenmueller M; Weiss CS; Bea F; Bekeredjian R; Schinke-Braun M; Izumo S; Katus HA; Hardt SE
    J Am Coll Cardiol; 2009 Dec; 54(25):2435-46. PubMed ID: 20082935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic exploration of the potential material basis and molecular mechanism of the Mongolian medicine Nutmeg-5 in improving cardiac remodeling after myocardial infarction.
    Liu T; Yan T; Jia X; Liu J; Ma R; Wang Y; Wang X; Liang Y; Xiao Y; Dong Y
    J Ethnopharmacol; 2022 Mar; 285():114847. PubMed ID: 34800647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction.
    Zhang Y; Elsik M; Edgley AJ; Cox AJ; Kompa AR; Wang B; Tan CY; Khong FL; Stapleton DI; Zammit S; Williams SJ; Gilbert RE; Krum H; Kelly DJ
    Int J Cardiol; 2013 Sep; 168(2):1174-85. PubMed ID: 23219315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.